The present invention encompasses compounds of Formula (I) as well as the pharmaceutically acceptable salts and hydrates thereof. The compounds are useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. Pharmaceutical compositions and methods of use are included. ##STR00001##

 
Web www.patentalert.com

< Spiroazacyclic compounds as monoamine receptor modulators

> Inhibition of STAT-1

~ 00422